BR9405954A - Compostos policíclicos e derivados dos mesmos composições farmacêuticas e método de tratamento de disfunção cognitiva ou neurológica - Google Patents
Compostos policíclicos e derivados dos mesmos composições farmacêuticas e método de tratamento de disfunção cognitiva ou neurológicaInfo
- Publication number
- BR9405954A BR9405954A BR9405954A BR9405954A BR9405954A BR 9405954 A BR9405954 A BR 9405954A BR 9405954 A BR9405954 A BR 9405954A BR 9405954 A BR9405954 A BR 9405954A BR 9405954 A BR9405954 A BR 9405954A
- Authority
- BR
- Brazil
- Prior art keywords
- derivatives
- pharmaceutical compositions
- same pharmaceutical
- polycyclic compounds
- treating cognitive
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4401293A | 1993-04-08 | 1993-04-08 | |
| US08/216,881 US5594001A (en) | 1993-04-08 | 1994-03-28 | Polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders |
| PCT/US1994/003673 WO1994024131A1 (en) | 1993-04-08 | 1994-04-04 | Novel polycyclic systems, and derivatives thereof, as neurotransmitter release enhancer useful in the treatment of cognitive disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9405954A true BR9405954A (pt) | 1995-12-26 |
Family
ID=26721086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9405954A BR9405954A (pt) | 1993-04-08 | 1994-04-04 | Compostos policíclicos e derivados dos mesmos composições farmacêuticas e método de tratamento de disfunção cognitiva ou neurológica |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5990132A (pt) |
| EP (1) | EP0693069A1 (pt) |
| JP (1) | JPH08509713A (pt) |
| CN (2) | CN1058495C (pt) |
| AU (1) | AU690906B2 (pt) |
| BR (1) | BR9405954A (pt) |
| CA (1) | CA2160112A1 (pt) |
| CZ (1) | CZ251995A3 (pt) |
| FI (1) | FI954775A (pt) |
| HU (1) | HUT74104A (pt) |
| IL (1) | IL109237A (pt) |
| LV (1) | LV11179B (pt) |
| NO (1) | NO308745B1 (pt) |
| NZ (1) | NZ265183A (pt) |
| OA (1) | OA10235A (pt) |
| PL (1) | PL178570B1 (pt) |
| RO (1) | RO115162B1 (pt) |
| RU (1) | RU2152944C1 (pt) |
| SI (1) | SI9420022A (pt) |
| SK (1) | SK124695A3 (pt) |
| WO (1) | WO1994024131A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5750528A (en) * | 1995-02-01 | 1998-05-12 | The Dupont Merck Pharmaceutical Company | Blockade of neuronal m-channels as a therapeutic approach to the treatment of neurological disease |
| US6262081B1 (en) * | 1998-07-10 | 2001-07-17 | Dupont Pharmaceuticals Company | Composition for and method of treating neurological disorders |
| JP5581607B2 (ja) | 2008-06-05 | 2014-09-03 | 住友化学株式会社 | 高分子化合物及びそれを用いた有機トランジスタ |
| PT2909204T (pt) | 2012-10-12 | 2019-03-21 | Dana Farber Cancer Inst Inc | Inibidores de gsk3 e métodos de utilização dos mesmos |
| US20150311450A1 (en) * | 2012-11-30 | 2015-10-29 | Lg Chem, Ltd. | New compounds and organic electronic device using the same |
| WO2015027015A1 (en) | 2013-08-22 | 2015-02-26 | Bristol-Myers Squibb Company | Imidazole-derived modulators of the glucocorticoid receptor |
| WO2015027021A1 (en) | 2013-08-22 | 2015-02-26 | Bristol-Myers Squibb Company | Imide and acylurea derivatives as modulators of the glucocorticoid receptor |
| CN109820853B (zh) | 2014-02-05 | 2022-05-10 | Vm肿瘤药物有限责任公司 | 取代的杂环化合物在制备治疗癌症药物中的用途 |
| GB201417369D0 (en) * | 2014-10-01 | 2014-11-12 | Redx Pharma Ltd | Compounds |
| US10927126B2 (en) * | 2016-11-07 | 2021-02-23 | Vanderbilt University | Positive allosteric modulators of the muscarinic acetylcholine receptor M4 |
| CA3058198A1 (en) | 2017-04-05 | 2018-10-11 | The Broad Institute, Inc. | Tricyclic compounds as glycogen synthase kinase 3 (gsk3) inhibitors and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1052346A (pt) * | 1964-09-09 | |||
| US5173489A (en) * | 1986-04-10 | 1992-12-22 | The Dupont Merck Pharmaceutical Co. | α,α-disubstituted aromatics and heteroaromatics as cognition enhancers |
| US4760083A (en) * | 1986-04-10 | 1988-07-26 | E. I. Dupont De Nemours & Company | 3,3-disubstituted indolines |
| CA2108889A1 (en) * | 1991-05-29 | 1992-11-30 | Robert Lee Dow | Tricyclic polyhydroxylic tyrosine kinase inhibitors |
| DE69218795T2 (de) * | 1992-01-16 | 1997-07-10 | Du Pont Merck Pharma | Verbindungen,die neurotransmitter freisetzen,um die lernfähigkeit zu erhöhen |
| RU2051151C1 (ru) * | 1992-01-16 | 1995-12-27 | Дзе Дюпон Мерк Фармасьютикал Компани | Азотсодержащие гетероциклические производные флуорена |
| US5272269A (en) * | 1992-01-16 | 1993-12-21 | The Du Pont Merck Pharmaceutical Company | Disubstituted polycyclic systems and preparative methods therefor |
| US5185447A (en) * | 1992-01-29 | 1993-02-09 | Du Pont Merck Pharmaceutical Company | Polycyclic ketones and preparative methods therefor |
| US5359070A (en) * | 1993-02-11 | 1994-10-25 | The Du Pont Merck Pharmaceutical Company | Unsymmetrical bis-imides as anticancer agents |
-
1994
- 1994-04-04 CN CN94191713A patent/CN1058495C/zh not_active Expired - Fee Related
- 1994-04-04 CZ CZ952519A patent/CZ251995A3/cs unknown
- 1994-04-04 RO RO95-01753A patent/RO115162B1/ro unknown
- 1994-04-04 SI SI9420022A patent/SI9420022A/sl unknown
- 1994-04-04 BR BR9405954A patent/BR9405954A/pt not_active Application Discontinuation
- 1994-04-04 AU AU65549/94A patent/AU690906B2/en not_active Ceased
- 1994-04-04 RU RU95120594/04A patent/RU2152944C1/ru active
- 1994-04-04 JP JP6523257A patent/JPH08509713A/ja active Pending
- 1994-04-04 PL PL94310997A patent/PL178570B1/pl unknown
- 1994-04-04 EP EP94913355A patent/EP0693069A1/en not_active Withdrawn
- 1994-04-04 HU HU9502929A patent/HUT74104A/hu unknown
- 1994-04-04 CA CA002160112A patent/CA2160112A1/en not_active Abandoned
- 1994-04-04 NZ NZ265183A patent/NZ265183A/en unknown
- 1994-04-04 SK SK1246-95A patent/SK124695A3/sk unknown
- 1994-04-04 WO PCT/US1994/003673 patent/WO1994024131A1/en not_active Application Discontinuation
- 1994-04-06 IL IL109237A patent/IL109237A/en not_active IP Right Cessation
-
1995
- 1995-10-06 FI FI954775A patent/FI954775A/fi unknown
- 1995-10-06 NO NO953989A patent/NO308745B1/no not_active IP Right Cessation
- 1995-10-06 OA OA60720A patent/OA10235A/en unknown
- 1995-10-09 LV LVP-95-302A patent/LV11179B/en unknown
-
1996
- 1996-06-17 US US08/664,631 patent/US5990132A/en not_active Expired - Fee Related
-
2000
- 2000-01-08 CN CN00100940A patent/CN1295072A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| RO115162B1 (ro) | 1999-11-30 |
| FI954775A0 (fi) | 1995-10-06 |
| CZ251995A3 (en) | 1996-01-17 |
| IL109237A0 (en) | 1994-07-31 |
| NO953989L (no) | 1995-12-07 |
| NO308745B1 (no) | 2000-10-23 |
| PL310997A1 (en) | 1996-01-22 |
| FI954775A (fi) | 1995-10-06 |
| SI9420022A (en) | 1996-10-31 |
| HU9502929D0 (en) | 1995-11-28 |
| NZ265183A (en) | 1997-11-24 |
| WO1994024131A1 (en) | 1994-10-27 |
| AU6554994A (en) | 1994-11-08 |
| JPH08509713A (ja) | 1996-10-15 |
| RU2152944C1 (ru) | 2000-07-20 |
| CN1295072A (zh) | 2001-05-16 |
| HUT74104A (en) | 1996-11-28 |
| EP0693069A1 (en) | 1996-01-24 |
| NO953989D0 (no) | 1995-10-06 |
| OA10235A (en) | 1997-10-07 |
| CA2160112A1 (en) | 1994-10-27 |
| CN1058495C (zh) | 2000-11-15 |
| PL178570B1 (pl) | 2000-05-31 |
| LV11179B (en) | 1997-06-20 |
| SK124695A3 (en) | 1996-06-05 |
| IL109237A (en) | 1998-02-08 |
| LV11179A (lv) | 1996-04-20 |
| CN1122135A (zh) | 1996-05-08 |
| US5990132A (en) | 1999-11-23 |
| AU690906B2 (en) | 1998-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69626104D1 (de) | Tricyclische carbamat-derivate zur inhibierung der g-protein funktion und zur behandlung von proliferativen erkrankungen | |
| BR9407799A (pt) | Composição de matéria método de tratamento e composição farmaceutica | |
| BR9406128A (pt) | Uso de um composto processo para o tratamento e/ou prevençao de distúrbios psicóticos composto composiçao farmacêutica processos para a preparaçao de um composto e de uma composiçao farmacêutica | |
| EE9900607A (et) | Imidasopürimidiinid ja imidasopüridiinid neuroloogiliste häirete käitlemiseks | |
| AU4032989A (en) | Method and compositions for the treatment and prevention of septic shock | |
| EP0707446A4 (en) | PHARMACEUTICAL COMPOSITIONS AND THEIR USE FOR TREATING NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOM COMPLEXES | |
| AU629777B2 (en) | Blocking agents of edrf effect or formation for the treatment of shock | |
| DE69432299D1 (de) | Multiple Botulinum Toxine zur Behandlung von neuromuskulären Störungen und Zuständen | |
| BR9005439A (pt) | Materiais anti-balisticos e processos de producao dos mesmos | |
| DE69627993D1 (de) | Trycyclische derivate zur inhibierung der g-protein funktion und für die behandlung von proliferativen erkrankungen | |
| FI963883A (fi) | Farmaseuttisia valmisteita ja lääkeaineita endoteelin toimintahäiriön ehkäisemiseksi ja hoitamiseksi | |
| BR9405954A (pt) | Compostos policíclicos e derivados dos mesmos composições farmacêuticas e método de tratamento de disfunção cognitiva ou neurológica | |
| HUP0200287A3 (en) | Pharmaceutical compositions for the treatment of neurological or neuropsychiatric disorders | |
| IL107449A0 (en) | Compositions and methods for reducing toxicity and increasing the efficacy of drugs | |
| AU3151097A (en) | Pharmaceutical for treating of neurological and neuropsychiatric disorders | |
| DE69405711D1 (de) | Behandlung von rueckstandsoel | |
| DE69825319D1 (de) | Präparat zur vorbeugung und behandlung von entzündungen | |
| FI961380A (fi) | Koostumuksia virusten aiheuttamien kasvainten ehkäisemiseksi ja hoitamiseksi | |
| FI942046A0 (fi) | Polysykliset yhdisteet ja menetelmä niiden valmistamiseksi | |
| MA23837A1 (fr) | Benzamides pour le traitement de degenerescenses neurologiques | |
| NO934832D0 (no) | Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose | |
| NO920983L (no) | Fremgangsmaate for behandling av nevrodegenerative tilstander | |
| DE69412178D1 (de) | Apparat zur Behandlung von Lagen | |
| DE69319127D1 (de) | Konjugat für den Nachweis und/oder Quantifizierung von biologischen Komponenten | |
| BR9307182A (pt) | Composições farmacêuticas de 2-oxindol-1-carboxamidas 3-substituídas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |